AFib 2gether™ 2.0.3

The AFib 2gether™ platform is a mobile tool designed to facilitate shared decision-making between patients and healthcare providers. It aims to enhance understanding of stroke risks associated with atrial fibrillation, a form of irregular heartbeat that is not due to a heart valve disorder. The primary objective is to support informed conversations during clinical encounters.

For patients and caregivers managing atrial fibrillation:

• Participants respond to tailored questions that generate a personalized stroke risk assessment, aiding clinicians in evaluating individual risk profiles.
• Users can identify and prioritize specific concerns related to atrial fibrillation and stroke risk, fostering focused discussions with healthcare providers.
• The Resources section offers educational content on atrial fibrillation, including explanations of medical terminology, instructional videos, and links to additional reliable sources, thereby promoting a better understanding of the condition and its associated risks.

For healthcare professionals involved in atrial fibrillation management:

• AFib 2gether™ supports shared decision-making conversations, aligning with 2016 ACC/AHA/HRS quality metrics emphasizing patient involvement in treatment planning for atrial fibrillation not caused by valvular disease.
• The app facilitates patient-provider interactions by providing structured tools to discuss stroke risk and treatment options effectively.

This application is intended solely for use within the United States. The health information provided is for educational purposes and should not replace professional medical advice. All patient care decisions must be made in consultation with a qualified healthcare provider, taking into account individual clinical circumstances.

Provided by Pfizer.